COVID vaccine effectiveness against omicron fell to 20% after six months but protection against severe disease still strong: Study Friday, May 5 by ABC News(NEW YORK) -- COVID-19 vaccine effectiveness against omicron infection fell to less than 20% after six months, according to a new analysis published Wednesday.Researchers from Italy and the United States looked at some of the most common vaccines used around the world, including Pfizer-BioNTech,... Read More.
Moderna says bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant Monday, November 14 by ABC News(NEW YORK) -- American biotechnology company Moderna announced Monday that a booster dose of its bivalent COVID-19 vaccine performs better against two circulating versions of the omicron variant, compared with a booster shot of its original formula.The news echoes a similar announcement made earlier... Read More.
Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant Friday, November 4 by ABC News(NEW YORK) -- American pharmaceutical company Pfizer and its German partner BioNTech announced Friday that a booster dose of their bivalent COVID-19 vaccine performs better against two circulating versions of the omicron variant, compared with a booster shot of their original vaccine.According to a... Read More.
Experts reveal how likely reinfection is from COVID with spread of omicron subvariant BA.5 Thursday, July 14 by ABC News(NEW YORK) -- Early in the COVID-19 pandemic, the prevailing theory was that if someone was infected with the virus, they were immune -- at least for a while.But a growing number of Americans seem to be contracting the virus more than once.A recent... Read More.
COVID hospitalizations forecast to increase amid concerns over new omicron subvariants Thursday, July 14 by ABC News(NEW YORK) -- For the first time since May, COVID-19-related hospital admissions are forecasted to increase again in the U.S., as highly infectious omicron subvariants continue to spread, according to updated forecasting models used by the Centers for Disease Control and Prevention.The models show... Read More.
Omicron subvariants threaten COVID-19 resurgence across US Tuesday, July 12 by ABC News(NEW YORK) -- Health officials are once again raising the alarm about the threat of a resurgence of COVID-19 infections across the country, as concerns grow about the new omicron subvariant, BA.5, which is now the dominant viral strain in the U.S.The BA.5 variant,... Read More.
Evolution is on omicron subvariants’ side Tuesday, June 28 by ABC News(NEW YORK) -- A new study finds that as the coronavirus continues to evolve, each new omicron subvariant is increasingly likely to lead to reinfection or breakthrough infection. However, researchers say current vaccines are still doing a good job of protecting people against severe... Read More.
Older Americans bore brunt of COVID-19 deaths during the omicron wave Thursday, June 2 by ABC News(NEW YORK) -- From the onset of the COVID-19 pandemic, the elderly have borne the brunt of the virus’ deadly wrath.Now, newly updated federal data shows that despite widespread vaccination among seniors, virus death rates among older Americans surged to near-record levels during the... Read More.
Pfizer three-dose COVID vaccine 80% effective against symptomatic omicron infection for youngest children Monday, May 23 by ABC News(NEW YORK) -- In long-awaited data, Pfizer said its 3-dose vaccine was 80% effective against symptomatic omicron COVID-19 infection among children 6 months to under 5 years old.The company cautioned that estimate was preliminary and could be adjusted as more data is collected. The... Read More.
Americans who haven’t had COVID are now in the minority following omicron surge Wednesday, April 27 by ABC News(ATLANTA) -- A new CDC analysis estimates that at least three out of every five Americans have antibodies that indicate a prior COVID-19 infection. Prior to the omicron-fueled surge in cases from December 2021 to February 2022, only an estimated one-third of people in... Read More.
